A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical modelsFeng Ren, Alex Zhavoronkov, Klaus K. Witte et al.|Nature Biotechnology|2024Cited by 265
Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery PlatformFrank W. Pun, Alex Zhavoronkov, Bonnie Hei Man Liu et al.|Frontiers in Aging Neuroscience|2022Cited by 99
Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engineFrank W. Pun, Alex Zhavoronkov, Geoffrey Ho Duen Leung et al.|Aging|2022Cited by 82
A comprehensive <scp>AI</scp>‐driven analysis of large‐scale omic datasets reveals novel dual‐purpose targets for the treatment of cancer and agingFrank W. Pun, Alex Zhavoronkov, Geoffrey Ho Duen Leung et al.|Aging Cell|2023Cited by 40